Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,485 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00182130 | Quality Initiative in Rectal Cancer (QIRC) Trial | unknown | N/A | 691 | Hamilton Health Sciences CorporationOTHER | 0 | Sep 16, 2005 | clinicaltrials |
| NCT00154986 | IGFBP-3 in Ovarian Cancer Invasion | unknown | N/A | 30 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00022893 |
| Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma |
| unknown |
| N/A |
| — |
| Corixa CorporationINDUSTRY |
| 2 |
| Jun 24, 2005 |
| clinicaltrials |
| NCT00022958 | Expanded Access Study of Iodine-131 Anti-B1 Antibody | unknown | N/A | — | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Sep 16, 2005source: clinicaltrials